Member Registration | Non-Member Registration |  Press Registration 
February 12, 2007
5:00PM -9:00PM
KPMG, Mountain View
5:00PM-6:00PM Poster Sessions/ Buffet Dinner/ Networking
6:00PM-7:00PM Startup Company Presentations / Q & A
7:00PM-7:30PM Poster Session/ Break
7:30PM-8:00PM Keynote Speaker: Professor Ronald Levy
8:00PM-8:30PM Keynote Speaker: Professor Nadir Arber 
8:30PM-9:00PM Poster Session/ Networking
Ronald Levy, MD, Professor of Medicine and Chief of the Division of Oncology, Department of Medicine at Stanford University

Dr. Ronald Levy’s landmark research on the basic immuno-biology of lymphocytes and on monoclonal antibodies led to the development of rituximab, a widely successful treatment for B-cell lymphoma. Dr Levy, a Harvard graduate, received his medical degree from Stanford. In 1982 he shared the first Armand Hammer Award for Cancer Research; the next year he received the Ciba-Geigy/Drew Award in Biomedical Research. In 1999 he received the American Society of Clinical Oncology Karnofsky Award and the prestigious General Motors Charles Kettering Prize. In 2000 he was awarded the Key to the Cure Award by the Cure for Lymphoma Foundation and the Medal of Honor by the American Cancer Society. Dr Levy has received international acclaim for his work using the body's own arsenal to fight cancer. He is currently conducting clinical trials of a lymphoma vaccine.

Nadir Arber, MD, MSc, MHA
Head - Integrated Cancer Prevention Center
Tel Aviv Medical Center and Tel Aviv University




Nadir Arber, studied Medicine at the Hebrew University in Jerusalem and received an MBA from Tel-Aviv University. Following that, he performed a fellowship in Gastroenterology at Tel-Aviv Medical Center. Next Dr. Arber conducted a research fellowship at the Cancer Center in Columbia University. Upon his return to Israel, he has established the GI Oncology unit at the Tel Aviv Medical Center. Dr. Nadir Arber is a professor of Medicine and Gastroenterology at Tel Aviv University and Tel Aviv Medical Center. He heads the GI Oncology Unit and the Integrated Cancer Prevention Center in Tel Aviv Medical Center. Dr. Arber has been the principle investigator of more than 20 international, multi center trials. Recently, he has established and is heading an international consortium of 106 centers from 32 countries. Most importantly, he is the co-lead principle investigator of the PreSAP study, an international, multi center trial, in the secondary prevention of colorectal cancer that was published last year in the NEJM, the most important medical journal. Dr. Arber had published more than 270 papers and received 80 grants & awards. He also had organized numerous international meetings in Israel and around the world.
Poster Session Companies
Media Partner

Members RSVP

Guests Registration

Participating Companies click here.

Apply to participate:click here

Copyrights 2008 Silicom Ventures LLC. All Rights Reserved